1.Stenting of the Superior Vena Cava and Left Brachiocephalic Vein with Preserving the Central Venous Catheter in Situ.
Peter ISFORT ; Tobias PENZKOFER ; Fabian GOERG ; Andreas H MAHNKEN
Korean Journal of Radiology 2011;12(5):629-633
Stenting of the central veins is well established for treating localized venous stenosis. The techniques regarding catheter preservation for central venous catheters in the superior vena cava have been described. We describe here a method for stent implantation in the superior vena cava and the left brachiocephalic vein, and principally via a single jugular venous puncture, while saving a left sided jugular central venous catheter in a patient suffering from central venous stenosis of the superior vena cava and the left brachiocephalic vein.
Brachiocephalic Veins/*pathology
;
Carcinoma, Bronchogenic/complications/drug therapy
;
*Catheterization, Central Venous/methods
;
Catheters, Indwelling
;
Constriction, Pathologic
;
Endovascular Procedures/*methods
;
Humans
;
Lung Neoplasms/drug therapy
;
Male
;
Middle Aged
;
Palliative Care
;
*Stents
;
Vena Cava, Superior/*pathology
2.Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.
Jonas SCHECK ; Philipp BRUNERS ; David SCHINDLER ; Christiane KUHL ; Peter ISFORT
Korean Journal of Radiology 2018;19(4):560-567
OBJECTIVE: To compare short-, mid-, and long-term follow-up ablation zone volume alterations as well as imaging features on contrast-enhanced computed tomography (CT) after irreversible electroporation (IRE) of primary and secondary liver tumors with findings subsequent to radiofrequency ablation (RFA). MATERIALS AND METHODS: Volume assessment of 39 ablation zones (19 RFA, 20 IRE) after intervention was performed at four time intervals (day 0 [t1; n = 39], day 1–7 [t2; n = 25], day 8–55 [t3; n = 28], after day 55 [t4; n = 23]) on dual-phase CT. Analysis of peripheral rim enhancement was conducted. Lesion's volume decrease relative to the volume at t1 was calculated and statistically analyzed with respect to patient's sex, age, ablation modality (IRE/RFA), and history of platinum-based chemotherapy (PCT). RESULTS: No influence of patient's sex or age on ablation volume was detected. The decrease in ablation zones' volume was significantly larger (p < 0.05 for all time intervals) after IRE (arterial phase, 7.5%; venous phase, 9.7% of initial volume) compared to RFA (arterial phase, 39.6%; venous phase, 45.3% of initial volume). After RFA, significantly smaller decreases in the ablation volumes, in general, were detected in patients treated with PCT in their history (p = 0.004), which was not detected after IRE (p = 0.288). In the arterial phase, peripheral rim enhancement was frequently detected after both IRE and RFA. In the venous phase, rim-enhancement was depicted significantly more often following IRE at t1 and t2 (pt1 = 0.003, pt2 < 0.001). CONCLUSION: As per our analysis, ablation zone volume decreased significantly in a more rapid and more profound manner after IRE. Lesion's remodeling after RFA but not IRE seems to be influenced by PCT, possibly due to the type of cell death induced by the different ablation modalities.
Catheter Ablation*
;
Cell Death
;
Drug Therapy
;
Electroporation*
;
Follow-Up Studies
;
Humans
;
Liver
;
Tumor Burden